Kenichi Kaida Selected Research

Miller Fisher Syndrome (Fisher Syndrome)

1/2021	Cholesterol-added antigens can enhance antiglycolipid antibody activity: Application to antibody testing.
9/2015	[Anti-glycolipid antibodies in Guillain-Barré syndrome and Fisher syndrome].
5/2013	[Antiganglioside complex antibody].
12/2012	Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics.
1/2012	[Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies].
1/2011	[Antiganglioside antibodies--their pathophysiological effects on Guillain-Barré syndrome and variants].
6/2010	Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenichi Kaida Research Topics

Disease

11	Guillain-Barre Syndrome 01/2021 - 07/2009
7	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 05/2022 - 12/2016
7	Miller Fisher Syndrome (Fisher Syndrome) 01/2021 - 06/2010
6	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 06/2006
4	Fever (Fevers) 04/2022 - 01/2014
4	Disease Progression 11/2021 - 12/2014
4	Polyneuropathies (Polyneuropathy) 01/2020 - 05/2013
3	Infections 01/2021 - 01/2012
3	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 01/2013
3	Neoplasms (Cancer) 12/2016 - 01/2015
2	Headache (Headaches) 04/2022 - 01/2018
2	Ophthalmoplegia (External Ophthalmoplegia) 04/2022 - 04/2022
2	Thymoma (Thymic Carcinoma) 01/2021 - 01/2019
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 01/2016
2	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2019 - 04/2013
2	Atrophy 08/2018 - 01/2016
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2015 - 03/2014
1	Paralysis (Palsy) 04/2022
1	Autoimmune Diseases of the Nervous System 01/2021
1	Progressive Encephalomyelitis with Rigidity 01/2021
1	Glioma (Gliomas) 01/2021
1	Myoclonus (Nocturnal Myoclonus) 01/2021
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021
1	Myasthenia Gravis 01/2019
1	Polymyositis 01/2019
1	Rhabdomyolysis 01/2019
1	Pharyngitis (Sore Throat) 01/2018
1	Collagen Diseases (Collagen Disease) 01/2018
1	Aseptic Meningitis 01/2018
1	Nausea 01/2018
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 05/2017
1	Muscular Dystrophies (Muscular Dystrophy) 05/2017
1	Muscle Cramp (Cramp) 05/2017
1	Type 2L Limb-Girdle Muscular Dystrophy 05/2017
1	Muscular Diseases (Myopathy) 12/2016
1	Dermatitis 01/2016
1	Dermatomyositis (Dermatopolymyositis) 01/2016
1	Multi-centric Castleman's Disease 10/2015
1	HIV Infections (HIV Infection) 10/2015

Drug/Important Bio-Agent (IBA)

15	AntibodiesIBA 01/2021 - 07/2009
7	Immunoglobulin G (IgG)IBA 04/2020 - 04/2013
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2006
4	Rituximab (Mabthera)FDA Link 05/2022 - 01/2015
4	Intravenous Immunoglobulins (IVIG)FDA Link 04/2022 - 11/2015
3	Immunoglobulin M (IgM)IBA 04/2022 - 05/2013
3	GangliosidesIBA 04/2022 - 06/2010
3	GlycolipidsIBA 01/2021 - 04/2013
3	AntigensIBA 01/2021 - 07/2009
2	ImmunosorbentsIBA 01/2021 - 12/2016
2	EnzymesIBA 01/2021 - 12/2016
2	AutoantibodiesIBA 04/2020 - 12/2016
2	DNA (Deoxyribonucleic Acid)IBA 05/2018 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2015
2	Creatine Kinase (Creatine Phosphokinase)IBA 05/2017 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 11/2015 - 12/2014
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2015 - 01/2015
1	Monoclonal AntibodiesIBA 05/2022
1	Therapeutic UsesIBA 05/2022
1	SteroidsIBA 04/2022
1	Immunoglobulins (Immunoglobulin)IBA 11/2021
1	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2021
1	AcidsIBA 01/2021
1	CholesterolIBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Glycine Receptors (Glycine Receptor)IBA 01/2021
1	GABA Receptors (GABA Receptor)IBA 01/2021
1	Semaphorin-3AIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2020
1	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2020
1	Chemokine CCL5IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Interleukin-4 (Interleukin 4)IBA 11/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2019
1	CytokinesIBA 11/2019
1	Interleukin-10 (Interleukin 10)IBA 11/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019
1	Interleukin-13IBA 11/2019
1	ChemokinesIBA 11/2019
1	Amantadine (Aman)FDA LinkGeneric 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	anti-titin autoantibodyIBA 01/2019
1	Cholinergic ReceptorsIBA 01/2019
1	loxoprofen (CS 600)IBA 01/2018
1	AlbuminsIBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	AnoctaminsIBA 05/2017
1	Oxidoreductases (Dehydrogenase)IBA 12/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2016
1	Coenzyme A (CoA)IBA 12/2016
1	transcriptional intermediary factor 1IBA 01/2016
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2016
1	Vasopressins (Vasopressin)IBA 10/2015

Therapy/Procedure

7	Therapeutics 05/2022 - 01/2014
3	Immunotherapy 11/2019 - 03/2014
2	Aftercare (After-Treatment) 11/2021 - 06/2006
1	Plasma Exchange 08/2018
1	Plasmapheresis 11/2015
1	Highly Active Antiretroviral Therapy (HAART) 10/2015